Data from experimentson the induction ofspecific-locus mutations in model systems are used in genetic risk assessment to estimate potential adverse effects in the human population. In such assessments with radiation or chemical mutagens, the fMolwin information is required: a) spontaneous and induced forward-mutation frequencies, b) dose-response curves for the overall induction ofspecific-locus mutations, c) genetic characterization ofspontaneous and induced mutations, and d) dose-response curves forthe different genotypic classes. Specific-locus aaysin most eukaryote assay systems provide only portions ofthe information required for such assessments. In recognition ofthe need for more detailed information for risk assent, a model system has been developed for specific-locus assays in Neurospora crussa. The adenine-3 (ad-3) specific-locus assay was modeled after the two-gene morphological specific-locus assay in the dilute-short-ear region of the mouse and detects forward-mutations at two closely linked loci: ad-34 and ad-3B. A computerized data management program has made it possible to obtain precise dose-response curves not only for the overall induction ofad-3 mutations, but also for various genotypic subclasses. In addition, computerized statistical programs have been developed to compare dose-response curves. These methods of analysis have shown that the overall dose-response curve for specific-locus mutations in the ad-3 region is a composite ofmany different genotypic subclasses. In addition, these subclasses may have very different induction kinetics from those of the overall dose-response curve for ad-3 mutations.
Introduction
One objective in genetic risk assessment is to use specificlocus assays in model systems as a means of approximating the impact of successful transmission of genetic damage resulting from exposure to mutagenic environmental agents on F1 progeny and subsequent generations in the human population. For these exercises, the model system ofchoice is the mouse (1) (2) (3) . There are extensive data on the genetic effects ofvarious radiations and chemical mutagens from studies with the morphological specific-locus assay system developed by Russell (4) , which detects mutations at seven loci.
Mouse data have been exceptionally useful in genetic risk assessment exercises for many years. However, one of the limitations ofthis approach is the time and expense ofthe experiments required to collect such specific-locus mutations, as well as their subsequent genetic characterization (5) (6) (7) . Because of the large populations of mice that would be required to provide enough data for any specific locus in the morphological specific-locus assay, dose-response curves combine the yields ofmutations at all seven loci as a practical necessity. In addition, the resources and time required for genetic and molecular analysis ofmutations at any given locus precludes the development ofdose-response curves for individual genotypic classes (e.g., gene/point muta- tions vs. multilocus deletion mutations).
For genetic risk assessment, to determine ifthere is a significant increase in the frequency of specific-locus mutations after mutagenic treatment, it is essential to be able to compare spontaneous and induced forward-mutation frequencies. Estimates of both spontaneous and induced forward-mutation frequencies must be made with a high degree of precision, especially with low-level exposures to mutagenic agents. It is equally essential to know whether the induced spectrum of specific-locus mutations is qualitatively different from those that occur spontaneously. If the induced spectrum is qualitatively different from that occurring spontaneously, then the impact of successful transmission to F. progeny could be quite different in terms of heterozygous effects (8) (9) (10) (11) . The ability to obtain dose-response curves makes it possible to extrapolate from the high-dose treatments used in the laboratory on model systems to the low exposures that may occur in nature to the human population. Genetic characterization of specific-locus mutations is essential in determining the impact ofsuccessful transmission of induced mutations to F, progeny. It may also provide an understanding of the "ground rules" associated with heterozygous effects of specific-locus mutations resulting either from gene/point mutation or multilocus deletion mutations (8) (9) (10) (11) .
In recognition ofthe need for a specific-locus assay system that could provide the type ofdata required to permit a comprehensive genetic risk assessment, a new model system was developed with Neurospora crassa (12) (13) (14) . The ad-3 assay was modeled after the dilute-short-ear (dse) morphological specific-locus assay in the mouse, developed by Russell (4) . In the mouse assay, two different types ofmorphological mutations can be detected in the dse region on chromosome 9 as changes in coatcolor and ear size. In some cases, double mutants are detected, usually as the result ofdeletion ofboth ofthese closely linked genes (7). It was possible to mimic this assay in Neurospora because there are two closely linked genes in thead-3 region, namely, ad-3A andad-3B. Becausead-3mutations accumulate areddish-purple pigment as well as havingarequirementforadenine, itwaspossible todevelop a direct method (14) for their recovery based on pigment accumulation. With this method, about 1.25 x 106 heterokaryotic survivors are incubated in 10L ofmedium (in a 12-L Florence flask) supplementedwith 12.5 mg/Ladenine and lOmg/Lnicotinic acid. After about 7 days ofincubation in the dark with aeration at 30(C, surviving conidia form colonies about 1-2 mm in diameter; colonies resulting from ad-3 mutations are reddish-purple, and nonmutant colonies are colorless. Thus, the ad-3 assay is both a morphological and a biochemical specific-locus assay system. The direct method has made it possible to recover from several hundred to several thousandad-3 mutations aftermutagenic treatment, even atlow frequencies ofinduction. This method alsoprovides very accurate estimates of overall ad-3 forward-mutation frequencies.
Typically, from 100 to 250ad-3 mutations are reserved for genetic characterization from each treatment series. The low frequency of spontaneous ad-3 mutations of0.39x 10-6 survivors usually ensures that such mutations areaminor fractionofsamples ofinduced ad-3 mutations in most forward-mutationexperiments. In addition, the collection of large numbers ofmutants of spontaneous origin from successive experiments has made it possible to determine the mutational spectrum ofspontaneous ad-3 mutations (15) .
Because ofthe efficacy ofthead-3 specific-locus assay, the large amount ofdata that can be collected in a typical experiment provides precisedose-response curves for survival andthe overall induction ofad-3 mutations. The computerized data management programdeveloped by Smith and de Serres (16) provides a useful mechanism fordata storage, tabulation, and statistical analysis of the data from forward-mutation experiments. Subsequent data generated by the genetic analysis of samples of ad-3 mutations from each treatment series make itpossible to resolve the overall dose-response curve for ad-3 mutations into its different genotypic components. Such data have provided striking evidence for mutagen specificity, both quantitative with regard to mutagenic potency and qualitative with regard to mutational spectra. These analyses have also shownthatthe majorgenotypic classes ofad-3 mutations, and various subclasses, may have different induction kinetics. In addition, classes of mutations (e.g., multiple-locus ad-3 mutations with closely linked recessive lethal mutations) that would notbeexpected to be recovered on thebasis oftargettheory (17) , havebeen foundtooccuratmarkedly higherfrequenciesthan expected (18) (19) (20) (21) . Data from studies with various chemical mutagens have shown that some agents produce specific-locus mutations in the ad-3 region predominantly or exclusively by gene/point mutation, whereas other agents produce both gene/ point mutations and multilocus deletion mutations (22) .
Computerized Data Management Program
A computerized data management program was developed by Smith and de Serres (16) to handle all aspects ofthe induction and genetic characterization of ad-3 mutations. The first computer printout from each experiment lists all ofthe data from forwardmutation experiments and provides dose-response curves for the survival of the treated cell populations, and induction of ad-3 mutations. These data are used to select at least three samples of ad-3 mutations from different treatment series for genetic analysis. The second printout lists all the data from such genetic analyses (23) on individual ad-3 mutations. These data are also collated into the three major genotypic classes: gene/point mutations, multilocus deletion mutations, and unknowns (mutations that grow too rapidly in the absence ofadenine). The three major genotypic classes and five subclasses that can be detected with these analyses are listed in Table 1 . In the second computer printout, the overall ad-3 forward-mutation frequency is used to determine the frequency of mutants in each major class or subclass. The data from all treatments are then used to develop a series of dose-response curves for each ofthese major classes and subclasses.
The next stage of analysis in the computerized data management program makes it possible to compare and combine data. With these programs it is possible to combine data from different experiments and/or compare dose-response curves for different genotypic classes with regard to slope or displacement on a loglog plot. This data management program has been used extensively since its development in 1968 for a wide variety of experiments with both ionizing and nonionizing radiations and various chemical mutagens (22) .
Genomic and Specific-Locus Assays that Provide a Database for Genetic Risk Assessment
In recognition of a need to assay the induction of recessive lethal mutations over the entire genome, Atwood and Mukai (24,25) developed a two-component heterokaryon ofthe haploid fungus Neurospora crassa. This approach was combined with the specific-locus assay approach in the development of the adenine-3 (ad-3) forward-mutation test in Neurospora by de Serres and co-workers (12, 14, 23) .
In Neurospora, adenine-3A (ad-3A) and adenine-3B (ad-3B) also are closely linked (about 0.1 map unit), with closely linked markers located both proximally (histidine-3 [his-3J, lysine-4 [lys-4], and histidine-2 [his-2]), and distally (nicotinic acid-2 [nic-2]). Also, there are 16 additional loci, with unknown biochemical requirements, that serve as markers in the ad-3 and immediately adjacent regions (26) . The ad-3 assay system was designed to detect mutations occurring at ad-3A and ad-3B as well as at other loci in the immediately adjacent genetic regions. The recovery of such mutations was not expected, however, since they should occur at extremely low frequencies on the basis of target theory (17) .
This assay is also unusual in that gene/point mutations can be readily distinguished from multilocus deletion mutations by a series of simple biochemical and genetic tests (23) . For example, gene/point mutations resulting from intragenic alterations in either ad-3A or ad-3B can be compensated for by adding adenine to the basic minimal medium. Such mutations are "reparable" on such a medium, and are designated ad-3R.
GENETIC RISK ASSESSMENT Multiple-locus(ad-3)IR mutation: multilocus deletion mutations covering the ad-3A and/or, ad-3B with a recessive lethal mutation in the mutation in the immediately adjacent regions
Multiple-locus (ad-3)IR mutation: this class is indistinguishable from multilocus deletion mutations covering the ad-3A, ad-3B, and/or nic-2 loci with present strains used as testers, and can not be detected individually
Pigmented isolates that grow too rapidly on minimal medium to be characterized.
However, multilocus deletion mutations that inactivate either one or both genes, as well as other genes in the immediately adjacent regions, cannot be compensated for by the addition ofadenine or any other supplement to the basic minimal medium. Such mutations are "irreparable" on such media and are designated ad_31R.
Genetic Characterization of ad-3 Mutations Using Classical Genetic Assays (19, 20) .
The different genotypes ofad-3 mutants that can be described on the basis of the data collected in the three genetic tests used for characterization are given in Table 1 . In this Table, the six genotypic subclasses expected by us initially (12,13) on the basis of target theory (17) are given. These genotypes consist of gene/point mutations at the ad-3A locus or the ad-3B locus, as well as multilocus deletion mutations covering one or both of these loci as well as the adjacent nic-2 locus, located distally. An additional group of49 genotypic subclasses that can be detected with this assay, many of which have actually been detected in various forward-mutation experiments, is discussed in de Serres (22 The dose-response curves for the induction ofad-3 mutations after treatment with chemical mutagens (Fig. 1) have demonstrated marked differences in slope and mutagenic potency (31) . The following classification scheme for mutagenic potency has been adopted: weak mutagens (1 -10 ad-3 mutations per 106 survivors), moderate mutagens (10 -100 ad-3 mutations per 106 survivors), strong mutagens (100 -1,000 ad-3 mutations per 106 survivors), and potent mutagens (1,000 to 10,000 ad-3 mutations per 106 survivors). The weakest mutagen is 2-aminopurine (32), and the most potent ever detected with this assay system is 2-amino-N6-hydroxyadenine (33). (Table 3) .
Spectrum of ad-3 Mutations Can Be Dose Dependent or Dose-Independent
Experiments with X-rays (13, 26, 37) have shown that X-rayinduced ad-3 mutations result from both major classes, gene/point mutations and multilocus deletion motions, but that the percentages ofad-3 mutations in each class is dose-dependent over a wide range ofsurvivals and forward-mutation frequencies.
Experiments with ultraviolet light [UV (36) ] have shown that UV-induced ad-3 mutations also result from both gene/point mutations and multilocus deletion mutations. However, the percentages of ad-3 mutations in each major class is dosedependent over a comparable range of survivals and forwardmutation frequencies.
Association of ad-3 Mutation with a Recessive Lethal Mutations Elsewhere in the Genome Varies According to Agent and Dose
The specific-locus ad-3 assay system can detect recessive lethal mutations occurring outside ofthe ad-3 region on linkage group I or on the other six linkage groups. Studies with X-rays (21) have shown that gene/point mutations with a recessive lethal elsewhere in the genome (ad-3R + RL) increase as the square of X-ray dose; thus, such mutations are dose-dependent. At very high X-ray doses, the presence of additional sites of recessive lethal damage elsewhere in the genome must be taken into consideration in genetic risk assessment. Such damage could be transmitted to F. progeny.
Such ad-3 mutations with additional sites of recessive lethal damage are also found in experiments with such chemicals as procarbazine (34) and 2-amino-N6-hydroxyadenine (33) , and the frequencies of such mutations are also dose-dependent. In the latter case, from 3 to 70% ofad-3 gene/point mutations can have a recessive lethal mutation elsewhere in the genome (de Serres and Brockman, unpublished data). The presence of additional sites of recessive lethal damage elsewhere in the genome in specific-locus mutations is important fbr extrapolation ofdata on their induction to overall risk to the genome. Ifthe frequency of such multiple-locus mutations is high, then genetic risk could be grossly underestimated.
Frequency of Multiple-Locus Mutations with Closely Linked Recessive Lethal Mutations Is Higher Than Expected on Target Theory
It was assumed that multiple-locus mutations, especially those resulting from mutations in closely linked genes, such as ad-3A and ad-3B, would be the product oftheir individual frequencies. Thus, if the forward-mutation frequency for an X-ray-induced ad-3A mutant was 1 x 10-6 and an ad-3B mutant was 2 x 10-6, the frequency of X-ray induced ad-3A ad-3B double mutants should be 2 x 10-"2. Two different classes of multiple-locus mutation with closely linked recessive lethal mutations can be distinguished (Table 1) . Either gene/point mutations or multilocus deletion mutations can occur in combination with closely linked recessive lethal mutations (ad-3R + RL CL or jd_3IR + RLCL).
In our experiments with X-ays, for example, such multiplelocus mutations were found to occur at much higher frequencies (18) (19) (20) (21) 30 ) than expected on the basis oftarget theory (17) . The large numbers ofsuch mutants recovered with the ad-3 forwardmutation assay have provided sufficient data to investigate the induction kinetics of these two unexpected subclasses of ad-3 
Abbreviations: MMS, methylmethanesulfonate; El, ethylenimine; PMMT, I-phenyl-3-monomethyltriazene; PDMT, 1-phenyl-3-dimethyltriazene; DEP, 1,2,4,5-diepoxypentane; DEO, 1,2,7,8-diepoxyoctane; HYC, hycanthone methanesulfonate; LUC, leucanthone hydrochloride; IA-3, hycanthone methanesulfonate indazole analog; IA-4, leucanthone methanesulfonate indazole analog; IA-5, hycanthone methanesulfonate indazole analog; EDB, ethylene dibromide; 2AP, 2-aminopurine. mutations (21) . Both classes increase as the square ofX-ray dose.
These data are somewhat surprising because on the basis oftarget theory, some of the ad-3 mutations with multiple sites of recessive lethal damage would require from three to eight events to account for their induction.
These findings must also be taken into account in genetic risk assessment because there is a high probability (approaching 20% at high X-ray doses) that specific-locus mutations will have at least one closely linked site of recessive lethal damage. Unexpectedly high frequencies of multiple-locus mutations with closely linked recessive lethal mutations have also been ibund in our experiments with ethylene dibromide (31), 2-aminopurine (32), and 2-amino-N6-hydroxyadenine (33), but not with procarbazine (34) .
Results parallel to those found in Neurospora also have been found in in vivo germinal specific-locus systems in both the mouse and Drosophila. In the mouse, multiple-locus mutations with closely linked sites ofdamage were identified ty Russell and Rinchik (7) among X-ray-induced specific-locus mutations in the dse region. These mutations were designated "skipping mutations." In Drosophila, multiple-locus mutations were found among X-ray-induced specific-locus mutations at the white locus in the repair-deficient strain mus-201 (38) . In both organisms, the "exceptional" mutants are similar to the X-ray-induced multiplelocus (ad-3)"R mutations in Neurospora.
The high frequency of such multiple-locus mutations indicates a much higher, and more extensive, type ofgenetic damage occurring at specific loci than was originally anticipated on the basis oftarget theory (17) . Again, these data provide evidence for more complex and extensive genetic damage at specific loci that must be taken into account in genetic risk assessment. In addition, the frequency and type of such multiple-locus mutations may well vary as a function of mutagenic origin.
Spectrum of Multilocus Deletion Mutations in the ad-3 Region Is Mutagen Dependent
Comparisons between the ad-3 mutations classified as multilocus deletion mutations have revealed marked differences as a function of mutagenic origin (31, 39) . The five different genotypic classes can be ranked as a function of size as follows; (ad_3A)IR, (ad_3B)IR, (ad-3A ad_3B)R, (ad-3B nic-)IR, (ad-3A ad-3B nic-2)'. In Table 4 , samples of ad-3 mutations induced by methyl methanesulfonate (MMS), ethylene dibromide (EDB), 1,2,7,8,-diepoxyoctane (DEO), and hycanthone methanesulfonate (HYC) are compared with those of spontaneous (SP) origin. In addition, our earlier studies (31) showed that X-rayinduced multilocus deletion mutations are larger than UVinduced multilocus deletion mutations. These data show differences in the percentages ofboth radiation and chemically induced ad-3 mutations resulting from multilocus deletion mutations as well as marked differences in the size ofsuch mutations. It is particularly interesting that 78.4% (69/88) of the HYC-induced multilocus deletion mutations are in the largest size class in contrast to MMS, which has only 3.4% (1/29) in this class.
The conclusion that can be drawn from such data is that different mutagens not only produce varying frequencies of specificlocus mutations resulting from multilocus deletion mutations but that there are marked differences between their sizes.
Modification of Traditional Methods of Genetic Risk Assessment
The traditional methods ofgenetic risk assessment for ionizing radiation-induction mutations have been reviewed by Sankaranarayanan (40) . These methods were originally developed to make maximum use of limited data from wholeanimal model systems. There were inadequate data on both spontaneous and induced forward-mutation frequencies as well as on the spectra of spontaneous and induced mutation in particular genes.
The most widely used model system for human genetic risk assessment is the mouse. However, numbers of mice must be screened to obtain specific-locus mutations with either the morphological (4) or the biochemical (41-) specific-locus assay. As a result, it is necessary to use data for the induction offorwardmutations at many loci, rather than at individual loci, to obtain dose-response curves after radiation treatment. Because there are limited data on mutation-induction at any given specific locus, it is generally assumed that the spectrum of specific-locus mutation is dose independent. It is also assumed, in the lack of sufficiently large samples of spontaneous and induced mutants, that the mutational spectra are identical. As a result, the doubling dose method (the amount of radiation required to produce as many mutations as those occurring spontaneously) is used to provide a mechanism for estimation of human genetic risk (42) .
Data from forward-mutation experiments with the ad-3 specific-locus assay can be used to supplement data from experiments with the mouse and to develop a more comprehensive approach to genetic risk assessment. The data on spontaneous ad-3 forward-mutations (Table 4) indicate that this spectrum is not only clearly different from those ad-3 mutations induced by MMS, EDB, DEO, and HYC, but also from X-ray-induced mutations (26, 37) . In addition, Webber and de Serres (13) demonstrated that the spectrum of ad-3 forward-mutations is dose dependent. These observations have been confirmed and extended in more recent studies (26, 37) , all ofwhich have shown that gene/point mutations increase linearly with X-ray dose, whereas multilocus deletion mutations and multiple-locus mutations increase as the square of X-ray dose.
It is also generally assumed (1-3) that most X-ray-induced specific-locus mutations will be recessive. However, X-rayinduced multilocus deletion mutations in the dilute-short-ear region ofthe mouse were demonstrated to show striking, allelespecific heterozygous effects (43) . Similar data were presented from studies of X-ray-induced ad-3A or ad-3B mutants resulting from multilocus deletion (44, 45) .
Recent studies with X-ray-induced multilocus deletions in Drosophila (46) have also shown allele-specific heterozygous effects. The conclusion that can be drawn from these studies on experimental organisms is that alleles of genes expected to show recessive Mendelian inheritance may show partial dominance in terms of heterozygous effects affecting growth rate, viability, longevity, etc. Thus, past assumptions of the ratio of dominant to recessive mutations that can be expected after exposure to radiation (1-3) may be in error, and this ratio may well vary as a function of mutagenic agent. Furthermore, if the spectrum (e.g., ratio ofgene/point mutations to multilocus deletion mutations) ofinduced specific-locus mutations is dose dependent, the ratio ofdominant to recessive mutations could vary as a function of forward-mutation frequency. Little is known about the mechanisms ofsuch allele-specific heterozygous effects from experiments with specific-locus mutations in the mouse or Drosophila and whether these effects are confined to multilocus deletion mutations. However, experiments with X-ray-induced ad-3 mutations resulting from gene/point mutation as well as those resulting from multilocus deletion mutation or multiplelocus mutation have demonstrated allele-specific heterozygous effects on linear growth rate in Neurospora (11, 47, 48) .
In conclusion, it is clear that much additional work must be done to investigate the impact of successful transmission ofboth spontaneous and induced mutations to the F. and subsequent generations both in the mouse and Drosophila. The exploratory studies on the heterozygous effects of X-ray-induced specificlocus mutations in Drosophila (46) , mouse (7, 43) , and Neurospora (44, 45) indicate that dominance/recessiveness is allele specific rather than gene specific. Ifheterozygous effects are also mutagen dependent, then all ofthese organisms must be used to further explore such effects and to obtain an understanding ofany differences in the behavior of mutants induced by different mutagens.
